Holen Sie sich die Stockscreener-App
10.06
0.00%
0.00
Schlusskurs vom Vortag:
$10.06
Offen:
$10.06
24-Stunden-Volumen:
46,009
Relative Volume:
0.34
Marktkapitalisierung:
$641.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$4.19M
KGV:
154.77
EPS:
0.065
Netto-Cashflow:
-
1W Leistung:
+0.20%
1M Leistung:
+0.50%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$10.06
$10.07
1-Wochen-Bereich:
$10.04
$10.07
52-Wochen-Spanne:
$9.87
$10.07
Drugs Made In America Acquisition Ii Corp Stock (DMII) Company Profile
Firmenname
Drugs Made In America Acquisition Ii Corp
Sektor
Branche
Telefon
954-870-3104
Adresse
420 LEXINGTON AVENUE, NEW YORK
Compare DMII vs LION, XXI, UMAC, BCSS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DMII
Drugs Made In America Acquisition Ii Corp
|
10.07 | 640.82M | 0 | 4.19M | 0 | 0.065 |
LION
Lionsgate Studios Corp
|
14.73 | 4.34B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
7.135 | 2.54B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
17.44 | 801.98M | 11.20M | -19.19M | -23.24M | -0.7527 |
BCSS
Bain Capital Gss Investment Corp
|
10.19 | 595.10M | 0 | 0 | 0 | 0.0729 |
Drugs Made In America Acquisition Ii Corp Aktie (DMII) Neueste Nachrichten
SAGU_u|SAGU_u.NB|Price:10.090|Chg%:0.04 - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
Layoff Tracker: AbbVie, Novartis slash US headcount - BioSpace
DMAA SEC FilingsDrugs Made In Amer Acqutn Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Eli Lilly and Co. | Pharmaceuticals, Biomedical Research, & Company - Britannica
Trump and Mark Cuban team up to take on America's drug pricing crisis - Fortune
HEIGHTS CAPITAL MANAGEMENT, INC's Drugs Made In America Acquisition II Corp(DMIIU) Holding History - GuruFocus
Shutterstock, Inc. 8-K Filing: UK CMA Approves Merger with Getty Images Holdings, Inc - Minichart
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
DMAA Price Today: Drugs Made In America Acquisition Corp. Stock Price, Quote & Chart | MEXC - MEXC
Drugs Made In America Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[10-Q] Drugs Made In America Acquisition Corp. Quarterly Earnings Report - Stock Titan
Drugs Made In America Acquisition II Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Drugs Made in America II (DMII) Q1 profit from trust interest amid going-concern risk - Stock Titan
Mizuho Financial Group reports 2,000,000 DMAA shares (DMAA) on 05/14/2026 - Stock Titan
Number of shareholders of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
'Drugs Made In America' SPAC Eyes $1B Deal With AI Platform - Law360
QRED|QuasarEdge Acquisition Units|Price:9.920|Chg%:-0.03 - TradingKey
Drugs Made In America Acquisition Corp (DMAA) and Power Analytics Global Corp Announce Definitive $1B AI Merger Agreement - Minichart
Vector Science and Therapeutics Corp.: Performance & Quotes, PAIN Stock Price on Toronto S.E. Exchange - marketscreener.com
Drugs Made In America Acquisition Announces PAGC Merger Deal - TipRanks
Drugs Made In America Acquisition to Merge With Power Analytics Global in Deal Valued Up to $1 Billion - TradingView
DMAA (NASDAQ: DMAA) to combine with Power Analytics Global; $1.0B target valuation - Stock Titan
DMAA (NASDAQ: DMAA) sets $1.0B PAGC merger with 90/10 ownership split - Stock Titan
Leadership Compensation Aligned With Future Business Combination - TipRanks
Shareholders Approve Extension of SPAC Business Combination Deadline - The Globe and Mail
DMAA Corp Extends Business Combination Deadline to April 29, 2027 Following Shareholder Approval – SEC 8-K Filing Update - Minichart
Drugs Made in America (NASDAQ: DMAA) holders redeem $99M from SPAC trust - Stock Titan
QLEP_u|Quantum Leap Acquisition Units (Proposed)|Price:10.010| - TradingKey
Talon Resources plc: Shareholders Board Members Managers and Company Profile | GB00BM8SQP62 - marketscreener.com
Talon Resources plc Stock (TAR)Quote London S.E. - marketscreener.com
Drugs Made In America Acquisition Updates Executive Compensation Agreements - The Globe and Mail
WENC_u|West Enclave Merger Units (Proposed)|Price:10.000|Chg%:-0.04 - TradingKey
Beng Kuang Marine Receives SGX Approval for Listing of 57 Million New Shares for Asian Sealand Acquisition - Minichart
Drugs Made In America Acquisition II Corp. Updates CFO and CEO Compensation Agreements and Share Grant Terms - Minichart
[8-K] Drugs Made In America Acquisition II Corp. Reports Material Event - Stock Titan
Drugs Made in America (NASDAQ: DMAA) details new CEO pay deal - Stock Titan
DRUMMOND VEN: Performance & Quotes, MACK Stock Price on Toronto S.E. Exchange - marketscreener.com
AmericanDrug (DMAAR) Stock: This Week (-4.28%) 2026-04-27Mid Cap Momentum - Newser
DMIIR Price History for Drugs Made IN America Acquisition II Stock - Barchart.com
ETFs Investing in Drugs Made In America Acquisition II Corp. Stocks - TradingView
Short Interest in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Grows By 8,397.5% - MarketBeat
DMAA | Drugs Made In America Insider Trading - Quiver Quantitative
Illumination Acquisition Corp I: Performance & Quotes, ILLU Stock Price on Nasdaq Exchange - marketscreener.com
AlphaTON Capital Corp. (ALP) - Minichart
Pfizer Inc. | Pharmaceuticals, Vaccines & Company History | Britannica Money - Britannica
DMII Price History for Drugs Made IN America Acquisition II Stock - Barchart.com
DMAAR Price History for Drugs Made IN America Acquisition Corp. Rights Stock - Barchart.com
Centiel AG: Shareholders Board Members Managers and Company Profile | CH0024666528 - marketscreener.com
USDrugAcqII (DMIIU) Stock Mutual Fund Trade (+0.10%) 2026-04-20Market Hype - Cổng thông tin điện tử tỉnh Lào Cai
AmDrug Acq2 (DMII) Stock: Is It a Compelling Buy (Idled) 2026-04-20Rating Change - Cổng thông tin điện tử tỉnh Lào Cai
Finanzdaten der Drugs Made In America Acquisition Ii Corp-Aktie (DMII)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):